ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ORIC fundamentals
ORIC Pharmaceuticals (ORIC) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.33 (YoY +32.65%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.33
+32.65%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
ORIC Pharmaceuticals (ORIC) key financial stats and ratios, covering profitability, financial health, and leverage.
ORIC Pharmaceuticals (ORIC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ORIC Pharmaceuticals (ORIC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ORIC Pharmaceuticals (ORIC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ORIC Pharmaceuticals (ORIC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ORIC Pharmaceuticals (ORIC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from ORIC Pharmaceuticals’s earnings call?What does ORIC Pharmaceuticals do and what are its main business segments?What is the market's earnings forecast for ORIC Pharmaceuticals next quarter?What is the revenue and EPS growth rate for ORIC Pharmaceuticals year over year?What were the key takeaways from ORIC Pharmaceuticals's earnings call?What is ORIC Pharmaceuticals's gross profit margin?What guidance did ORIC Pharmaceuticals's management provide for the next earnings period?Did ORIC Pharmaceuticals beat or miss consensus estimates last quarter?
